New drug tested for tough HPV cancers that Won't quit
Disease control
Completed
This early-stage trial tested a new drug called TGN-S11 in people with HPV-related cancers that had returned, resisted treatment, or spread. The main goal was to find the highest safe dose. The study involved 28 participants whose cancers had progressed despite standard treatment…
Phase: PHASE1 • Sponsor: Toragen, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC